Gerald L. Andriole, MD

Gerald L. Andriole, MD

Barnes-Jewish Hospital and Washington University School of Medicine

St. Louis, Missouri

Gerald L. Andriole, Jr., MD, is the Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish Hospital, the Siteman Cancer Center and Washington University School of Medicine in St. Louis, Missouri.

Dr. Andriole received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He trained in surgery at Strong Memorial Hospital and the University of Rochester and completed urology residency at Brigham and Women’s Hospital and Harvard Medical School. Subsequently, he was a fellow in Urologic Oncology at the National Cancer Institute in Bethesda, Maryland.

Dr. Andriole has over 30 years of consistent contributions in the areas of BPH and prostate cancer screening and prevention research. He has contributed well over 350 peer-reviewed publications and serves on the editorial boards of several prestigious journals. He is Chairman of the Prostate Committee of the National Cancer Institute’s Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and PI of the NIDDK Multidisciplinary Approach to Urologic Pelvic Pain (MAPP) and Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). He was Chairman of the Steering Committee of the REDUCE Prostate Cancer Prevention Trial as well as PI of the NIDDK Medical Therapy of Prostatic Symptoms (MTOPS) BPH trial, and of the NIDDK Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) study. He is a member of the American Urological Association, American Association for Cancer Research, the American Society of Clinical Oncology, American Surgical Association, the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons, among other societies.

Articles by Gerald L. Andriole, MD

Ask the Expert: Are More Patients Being Diagnosed with Metastatic Prostate Cancer Since USPSTF’s Recommendations?

Gerald L. Andriole, Jr., MD, Barnes-Jewish Hospital, St. Louis, Missouri, discusses whether more patients are being seen at diagnosis with metastatic prostate cancer since USPSTF’s screening recommendations. Interview produced by Prostatepedia Keywords: metastatic prostate cancer, U.S. Preventive Services Task Force, screening To View Other Presentations on Prostate Cancer Click...

Read More

What Are Ways to Improve PSA?

Gerald L. Andriole, Jr., MD, Washington University, St. Louis, Missouri, discusses ways to improve PSA by looking at recent studies and the latest USPSTF recommendations.     To view slides from Dr. Andriole’s presentation at the 18th Annual Future Directions in Urology Symposium, click here. Keywords: prostate cancer, USPSTF, biopsy, metastatic, focal therapy...

Read More

The “Who’s” of Genomic Markers: Who to Treat

Dr. Gerald L. Andriole, Jr. presented “The “Who’s” of Genomic Markers: Who to Treat” at the 27th annual International Prostate Cancer Update meeting on Wednesday, January 25, 2017.       Keywords: prostate cancer, metastasis, genomic markers, prolaris, prostatectomy, biopsy How to cite: Andriole, Gerald L.  “The “Who’s” of Genomic Markers: Who to Treat.” January 25, 2017. Accessed Dec 2017. Transcript The “Who’s” of Genomic Markers: Who to Treat   Everybody has seen this, talked about it, conventional biopsy, completely misleading. We don’t have to beat that any further. And so if you really want to know if the guy in...

Read More
  • 1
  • 2

Join the GRU Community

- Why Join? -